Safety and Clinical Activity of MK-3475 as Initial Therapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

被引：6
|
作者：
Balmanoukian, A. S. [1 ]
Rizvi, N. A. [2 ]
Garon, E. B. [3 ]
Patnaik, A. [4 ]
Gandhi, L. [5 ]
Leighl, N. B. [6 ]
Goldman, J. W. [7 ]
Eder, J. P. [8 ]
Johnson, E. A. [9 ]
Blumenschein, G. R. [10 ]
Gubens, M. A. [11 ]
Papadopoulos, K. P. [4 ]
Lubiniecki, G. M. [12 ]
Zhang, J. [13 ]
Niewood, M. [12 ]
Emancipator, K. [14 ]
Dolled-Filhart, M. [15 ]
Hanson, M. E. [16 ]
Hui, R. [17 ]
机构：
[1] Angeles Clin & Res Inst, Los Angeles, CA USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[4] South Texas Accelerated Res Therapeut, San Antonio, TX USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Princess Margaret Canc Ctr UHN, Toronto, ON, Canada
[7] Univ Calif Los Angeles, Santa Monica, CA USA
[8] Yale Univ, New Haven, CT USA
[9] Mayo Clin Florida, Jacksonville, FL USA
[10] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[11] Univ Calif San Francisco, San Francisco, CA 94143 USA
[12] Merck & Co Inc, Whitehouse Stn, NJ USA
[13] Merck & Co Inc, Gwynedd, PA USA
[14] Merck Res Labs, Rahway, NJ USA
[15] Merck & Co Inc, Rahway, NJ 07065 USA
[16] Merck & Co Inc, Rahway, NJ 07065 USA
[17] Westmead Hosp, Sydney, NSW, Australia
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.08.023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2
引用
收藏
页码：S1 / S2
页数：2
相关论文
共 50 条
  • [31] Salvage therapy in patients with advanced non-small cell lung cancer
    Bedano, Pablo M.
    Hanna, Nasser H.
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (06) : 582 - 587
  • [32] Correlation of clinical activity of pembrolizumab (MK-3475) with immunohistochemical staining for programmed death-1 ligand (PD-L1) in ≥50% of tumor cells in a prospective non-small cell lung cancer (NSCLC) validation population
    Garon, E. G.
    Rizvi, N. A.
    Leigh, N. B., I
    Hui, R.
    Eder, J. P.
    Patnaik, A.
    Aggarwal, C.
    Horn, L.
    Balmanoukian, A. S.
    Gubens, M. A.
    Felip-Font, E.
    Carceny Costa, E.
    Soria, J. C.
    Ahn, M. J.
    Arkenau, H. T.
    Lee, J. S.
    Robinet, G.
    Lubiniecki, G. M.
    Zhang, J.
    Emancipator, K.
    Rutledge, R.
    Dolled-Filhart, M.
    Gandhi, L.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 44 - 45
  • [33] Efficacy and Safety of Anlotinib in Combination with Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
    Han, B.
    Chu, T.
    Zhang, X.
    Zhong, H.
    Zhang, B.
    Wang, H.
    Gu, A.
    Zhang, W.
    Shi, C.
    Zhong, R.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S398 - S398
  • [34] Efficacy and Safety of Combing Anlotinib and Erlotinib as a First-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
    Han, B.
    Chu, T.
    Shi, C.
    Zhong, H.
    Zhang, W.
    Zhang, B.
    Zhong, R.
    Zhang, X.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S646 - S647
  • [35] Measures of aggressive care in advanced non-small cell lung cancer (NSCLC) patients
    McCannon, J.
    Jackson, V. A.
    Billings, J. A.
    Pirl, W. F.
    Greer, J.
    Lynch, T. J.
    Temel, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] FUNCTIONAL DECLINE IN PATIENTS WITH ADVANCED STAGE NON-SMALL CELL LUNG CANCER (NSCLC)
    Murnane, A.
    Krishnasamy, M.
    Denehy, L.
    Granger, C.
    Aranda, S.
    Mileshkin, L.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : S27 - S28
  • [37] Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC)
    Bearz, Alessandra
    Fratino, Lucia
    Spazzapan, Simon
    Berretta, Massimiliano
    Giacalone, Annalisa
    Simonelli, Cecilia
    Tirelli, Umberto
    LUNG CANCER, 2007, 55 (01) : 125 - 127
  • [38] Comorbidity and survival in advanced non-small cell lung cancer (NSCLC) veteran patients
    Chang, V. T.
    Hoover, D. R.
    Cogswell, J.
    Cholankeril, M.
    Badin, S.
    Yang, W.
    Yan, H.
    Gonzalez, M. L.
    Einhorn, J.
    Kasimis, B. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] Weekly paclitaxel (P) in patients with advanced non-small cell lung cancer (NSCLC).
    Nakagawa, K
    Fukuoka, M
    Saijo, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 704S - 704S
  • [40] Amivantamab in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Nagasaka, M.
    Goto, K.
    Gomez, J.
    Hida, T.
    Shu, C.
    Lee, C. K.
    Park, K.
    Cho, B. C.
    Lee, J.
    Ou, S.
    Bestvina, C.
    Natale, R.
    Haddish-Berhane, N.
    Bhattacharya, A.
    Verheijen, R.
    Agrawal, T.
    Knoblauch, R.
    Govindan, R.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1116 - S1116
12345